Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 38 of 38 entries
View as:

A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01605825 Org: User:
Start: 05/31/12 End: 03/31/13 Due: 03/31/14

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01258387 Org: User:
Start: 12/31/10 End: 03/31/13 Due: 03/31/14

A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode

Phase: N/A Priority: Normal
NCT ID: NCT01417078 Org: User:
Start: 09/30/11 End: 03/31/13 Due: 03/31/14

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01316055 Org: User:
Start: 01/31/11 End: 09/30/11 Due: 09/30/12

An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT01535664 Org: User:
Start: 01/31/12 End: 06/30/12 Due: 06/30/13

Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

Phase: N/A Priority: Normal
NCT ID: NCT03887884 Org: User:
Start: 03/05/19 End: 06/28/19 Due: 06/28/20

A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial

Phase: N/A Priority: Normal
NCT ID: NCT01839279 Org: User:
Start: 04/30/13 End: 05/31/14 Due: 05/31/15

A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02633007 Org: User:
Start: 12/31/15 End: 05/31/16 Due: 05/31/17

Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.

Phase: N/A Priority: Normal
NCT ID: NCT02422940 Org: User:
Start: 04/30/15 End: 01/31/17 Due: 01/31/18

AC105 in Patients With Acute Traumatic Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT01750684 Org: User:
Start: 07/31/13 End: 05/31/15 Due: 05/31/16

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Phase: N/A Priority: Normal
NCT ID: NCT02240030 Org: User:
Start: 11/30/14 End: 12/31/16 Due: 12/31/17

Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT01683838 Org: User:
Start: 06/30/02 End: 02/29/04 Due: 02/28/05

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Phase: N/A Priority: Normal
NCT ID: NCT01777555 Org: User:
Start: 04/30/13 End: 01/31/14 Due: 01/31/15